DK3145493T3 - Fremgangsmåder og sammensætninger vedrørende exosomer - Google Patents

Fremgangsmåder og sammensætninger vedrørende exosomer Download PDF

Info

Publication number
DK3145493T3
DK3145493T3 DK15796048.5T DK15796048T DK3145493T3 DK 3145493 T3 DK3145493 T3 DK 3145493T3 DK 15796048 T DK15796048 T DK 15796048T DK 3145493 T3 DK3145493 T3 DK 3145493T3
Authority
DK
Denmark
Prior art keywords
exosomes
methods
compositions relating
relating
compositions
Prior art date
Application number
DK15796048.5T
Other languages
English (en)
Inventor
S Alexander Mitsialis
Stella Kourembanas
Konstantinos Sdrimas
Original Assignee
Childrens Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Medical Center filed Critical Childrens Medical Center
Application granted granted Critical
Publication of DK3145493T3 publication Critical patent/DK3145493T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0668—Mesenchymal stem cells from other natural sources

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
DK15796048.5T 2014-05-18 2015-05-15 Fremgangsmåder og sammensætninger vedrørende exosomer DK3145493T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461994974P 2014-05-18 2014-05-18
PCT/US2015/031008 WO2015179227A1 (en) 2014-05-18 2015-05-15 Methods and compositions relating to exosomes

Publications (1)

Publication Number Publication Date
DK3145493T3 true DK3145493T3 (da) 2022-10-31

Family

ID=54554566

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15796048.5T DK3145493T3 (da) 2014-05-18 2015-05-15 Fremgangsmåder og sammensætninger vedrørende exosomer

Country Status (11)

Country Link
US (2) US10624929B2 (da)
EP (1) EP3145493B1 (da)
JP (2) JP6773563B2 (da)
KR (1) KR20170005854A (da)
CN (2) CN113817672A (da)
AU (1) AU2015264519B2 (da)
CA (1) CA2949083C (da)
DK (1) DK3145493T3 (da)
ES (1) ES2929725T3 (da)
IL (1) IL249011B (da)
WO (1) WO2015179227A1 (da)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6204830B2 (ja) 2011-03-11 2017-09-27 チルドレンズ メディカル センター コーポレーション 間葉系幹細胞エキソソームに関連する方法および組成物
JP2016528295A (ja) 2013-08-22 2016-09-15 アクセルロン ファーマ， インコーポレイテッド Ｔｇｆ−ベータ受容体ｉｉ型変異体およびその使用
EP3071215B1 (en) 2013-11-21 2020-01-08 The Brigham and Women's Hospital, Inc. Compositions and methods for treating pulmonary hypertension
KR20170005854A (ko) 2014-05-18 2017-01-16 칠드런'즈 메디컬 센터 코포레이션 엑소솜과 관련된 방법 및 조성물
AU2015296037B2 (en) 2014-08-01 2021-04-29 The Brigham And Women's Hospital, Inc. Methods and compositions relating to treatment of pulmonary arterial hypertension
WO2016176500A1 (en) * 2015-04-28 2016-11-03 The Texas A&M University System Scalable production of standardized extracellular vesicles, extracellular vesicle preparations and uses thereof
US10702581B2 (en) 2015-05-04 2020-07-07 Ilias Biologics Inc. Compositions containing protein loaded exosome and methods for preparing and delivering the same
WO2018062973A1 (en) * 2016-09-30 2018-04-05 Cellex Life Sciences, Incorporated Compositions containing protein loaded exosome and methods for preparing and delivering the same
JP7320350B2 (ja) 2015-08-04 2023-08-03 アクセルロン ファーマ インコーポレイテッド 骨髄増殖性障害を処置するための方法
US20190117837A1 (en) * 2016-03-02 2019-04-25 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Matrix bound nanovesicles and their use
US20190060367A1 (en) * 2016-03-03 2019-02-28 Henry Ford Health System 3-d collagen scaffold-generated exosomes and uses thereof
CN105861430B (zh) * 2016-04-29 2019-07-23 南京大学 一种外泌体、外泌体的制备方法及其在制备治疗脓毒症药物或者制剂中的应用
KR20230067715A (ko) * 2016-06-17 2023-05-16 유나이티드 쎄러퓨틱스 코포레이션 향상된 효능을 가진 세포외 소포
US10946047B2 (en) 2016-06-17 2021-03-16 United Therapeutics Corporation Extracellular vesicles with enhanced potency
AU2017305064B2 (en) * 2016-08-03 2023-03-16 Life Science Institute, Inc. Amelioration and treatment of chronic lung disease using pluripotent stem cells
US20210283183A1 (en) * 2016-08-05 2021-09-16 Exostemtech Co., Ltd. Composition for preventing or treating pulmonary fibrosis containing exosome isolated from adipose-derived stem cell as active ingredient
US11596656B2 (en) 2016-08-23 2023-03-07 Albert Einstein College Of Medicine Stem cell-produced microvesicles for treating tendon pathologies
US20220175842A1 (en) * 2016-11-02 2022-06-09 Darwin J. Prockop Exosomes and uses thereof in diseases of the brain
EP4364799A3 (en) * 2017-01-11 2024-07-17 Paracelsus Medizinische Privatuniversität Salzburg - Privatstiftung Mesenchymal stem cell-derived extracellular vesicles and their medical use
KR101973284B1 (ko) * 2017-01-16 2019-04-29 사회복지법인 삼성생명공익재단 신생아 ｈｉｅ 치료용 조성물
CN110520140A (zh) * 2017-04-19 2019-11-29 菲格内有限责任公司 成纤维细胞衍生的外泌体刺激血管生成
CN107137700B (zh) * 2017-04-27 2021-01-12 张国瑜 一种基于干细胞源外泌体的组合物及其在制备治疗心肌梗死的药物中的应用
PL3628049T3 (pl) 2017-05-04 2023-09-25 Acceleron Pharma Inc. Białka fuzyjne receptora TGF-beta typu II i ich zastosowania
CA3060956A1 (en) 2017-05-05 2018-11-08 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Ocular applications of matrix bound vesicles (mbvs)
JP7037205B2 (ja) * 2017-06-30 2022-03-16 エクソコバイオ インコーポレイテッド 幹細胞由来のエキソソームを有効成分として含む組成物のかゆみの抑制又は改善の用途
CN107349220A (zh) * 2017-07-26 2017-11-17 深圳市泰华细胞工程有限公司 一种包含成纤维细胞外泌体的制剂及其用途
CN111212653A (zh) * 2017-08-15 2020-05-29 儿童医学中心公司 经纯化间充质干细胞外排体及其用途
WO2019083201A2 (ko) * 2017-10-24 2019-05-02 주식회사 엑소코바이오 지방줄기세포 유래의 엑소좀을 유효성분으로 포함하는 조성물의 신장 기능 개선 용도
GB201718681D0 (en) * 2017-11-13 2017-12-27 Evox Therapeutics Ltd Protein engineered extracellular vesicles
JP2021506801A (ja) * 2017-12-14 2021-02-22 メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ 精製されたエクソソーム生成物、作成方法及び使用方法
CN108318688B (zh) * 2018-01-10 2019-08-06 浙江大学 外周血外泌体中Smad3蛋白作为分子标记的应用、肝癌检测试剂盒
WO2019168977A1 (en) * 2018-02-27 2019-09-06 Musc Foundation For Research Development Compositions and methods for treating and/or preventing sepsis and/or inflammatory conditions
KR102015502B1 (ko) 2018-03-29 2019-08-28 아키소스템바이오스트래티지스(주) 인간 제대로부터 줄기세포를 분리하는 방법
CA3095716A1 (en) 2018-04-10 2019-10-17 Brainstorm Cell Therapeutics Ltd. Cell-type specific exosomes and use thereof
EP3781131A4 (en) * 2018-04-19 2022-06-01 Board of Regents, The University of Texas System THERAPEUTIC MODULATION OF TUMOR SUPPRESSORS USING EXOSOMES
JP7538044B2 (ja) * 2018-04-30 2024-08-21 ザ チルドレンズ メディカル センター コーポレーション 間葉系間質細胞エキソソームおよびそれらの使用
CN108865985A (zh) * 2018-06-22 2018-11-23 山东省职业卫生与职业病防治研究院 一种干细胞源外泌体干预上皮-间质转化的方法
CN109266603A (zh) * 2018-08-29 2019-01-25 浙江大学 一种提高心梗疗效的外泌体及应用
CN110876734A (zh) * 2018-09-06 2020-03-13 杨昆德 包含胞外囊泡的制剂、用以制备该制剂的方法及其用途
CN109596841B (zh) * 2019-01-14 2020-04-14 浙江大学 外泌体TβRII蛋白作为标志物在制备乳腺癌检测试剂盒中的应用
KR102300686B1 (ko) 2019-02-15 2021-09-08 이귀선 모터 포인트의 전기 자극으로 발생된 근전도 신호를 감지하여 운동점을 확인할 수 있는 근전도 탐지부를 포함하는 근감소증치료 전기근육자극 장치
CN110115769A (zh) * 2019-04-08 2019-08-13 浙江大学 一种脑靶向外泌体及其制备方法和应用
US20240024220A1 (en) * 2019-05-11 2024-01-25 Youngsuk Yi Neurotoxin compositions and methods
TW202122569A (zh) * 2019-08-09 2021-06-16 日商宇部興產股份有限公司 應用小片多孔膜的細胞培養法
US20230098890A1 (en) * 2020-02-13 2023-03-30 Figene, Llc Treatment of cerebral palsy using fibroblasts
WO2021207192A1 (en) * 2020-04-08 2021-10-14 Figene, Llc Methods and compositions for allergy and asthma treatment using fibroblasts
JP6967308B1 (ja) * 2020-06-30 2021-11-17 国立大学法人高知大学 胎児付属物由来組織細胞培養上清を含む脳神経障害治療剤
CN114377215B (zh) * 2020-10-16 2023-01-31 生物岛实验室 界面修饰的疝气片及其制备方法
CN115212234B (zh) * 2021-10-22 2023-11-10 武汉大学中南医院 纤维网状细胞来源的外泌体在制备用于治疗和/或预防脓毒症急性肾损伤的药物中的应用
WO2023182507A1 (ja) * 2022-03-24 2023-09-28 北海道公立大学法人 札幌医科大学 薬学的組成物、間葉系幹細胞の三次元培養物の製造方法、エクソソームの製造方法、および薬学的組成物の製造方法
CN115109741A (zh) * 2022-05-17 2022-09-27 华中农业大学 一种脂质筏的快速分离方法

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2766205B1 (fr) 1997-07-16 2002-08-30 Inst Nat Sante Rech Med Nouveau procede de sensibilisation de cellules presentatrices d'antigene et nouveaux moyens pour la mise en oeuvre du procede
US20040214783A1 (en) 2002-05-08 2004-10-28 Terman David S. Compositions and methods for treatment of neoplastic disease
US8021847B2 (en) 2004-06-02 2011-09-20 Proxy Life Science Holdings, Inc. Microvesicle-based compositions and methods
US8337815B2 (en) 2004-12-23 2012-12-25 Discovery Laboratories, Inc. Pulmonary surfactant formulations
WO2006110582A1 (en) 2005-04-08 2006-10-19 Xcyte Therapies, Inc. Compositions and methods for the treatment of burns and sepsis
CN101341244A (zh) 2005-09-02 2009-01-07 新加坡科技研究局 获取间质干细胞的方法
JP2010500047A (ja) 2006-08-15 2010-01-07 エージェンシー フォー サイエンス，テクノロジー アンド リサーチ 間葉系幹細胞馴化培地
PT2578081E (pt) 2006-10-11 2016-06-17 Massachusetts Inst Technology Composições, métodos e dispositivos para o tratamento de doenças hepáticas
EP1944361A1 (en) 2007-01-11 2008-07-16 INSERM (Institut National de la Santé et de la Recherche Médicale) A method for expanding monocytes
CA2711218C (en) 2008-01-04 2019-08-06 Lydac Neuroscience Limited A method of producing a population of differentiated cells
KR101640381B1 (ko) 2008-02-22 2016-07-18 에이전시 포 사이언스, 테크놀로지 앤드 리서치 중간엽 줄기세포 입자
EP2456861A4 (en) 2009-07-23 2013-12-04 Agency Science Tech & Res PRENATAL MESENCHYMAL STEM CELLS
WO2011053257A2 (en) 2009-11-02 2011-05-05 Agency For Science, Technology And Research (A*Star) Methods of monitoring cellular states
KR101189655B1 (ko) 2010-06-30 2012-10-11 성균관대학교산학협력단 줄기세포 배양액을 포함하는 폐질환 치료용 조성물
CN101890050B (zh) 2010-07-14 2012-07-04 江苏大学 脐带间质干细胞来源膜性囊泡及其应用
AU2011288262A1 (en) * 2010-08-13 2013-04-04 The University Court Of The University Of Glasgow Therapeutic uses of microvesicles and related microRNAs
WO2012115885A1 (en) 2011-02-22 2012-08-30 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Circulating biomarkers
JP6204830B2 (ja) * 2011-03-11 2017-09-27 チルドレンズ メディカル センター コーポレーション 間葉系幹細胞エキソソームに関連する方法および組成物
BR112013032232A2 (pt) * 2011-06-16 2016-09-20 Caris Life Sciences Switzerland Holdings S A R L método de caracterização de câncer através do uso de biomarcador de ácido nucleico
ITTO20111183A1 (it) 2011-12-21 2013-06-22 Univ Degli Studi Torino Mezzo condizionato ottenuto da cellule staminali mesenchimali placentari e suo uso nel trattamento terapeutico della preeclampsia
US9427450B2 (en) 2012-01-31 2016-08-30 Xon Cells, Inc. Therapeutic immune modulation by stem cell secreted exosomes
WO2013150303A1 (en) * 2012-04-03 2013-10-10 Reneuron Limited Stem cell microparticles
KR101399056B1 (ko) * 2012-04-16 2014-05-27 연세대학교 산학협력단 줄기세포-유래 미세소포체를 유효성분으로 포함하는 신경질환 예방 또는 치료용 약제학적 조성물
US10231997B2 (en) 2012-08-15 2019-03-19 The University Of Chicago Exosome-based therapeutics against neurodegenerative disorders
ES2927175T3 (es) 2013-02-12 2022-11-03 Reneuron Ltd Método de producción de micropartículas
SG11201508433TA (en) 2013-04-12 2015-11-27 Andaloussi Samir El Therapeutic delivery vesicles
WO2015018915A1 (de) 2013-08-07 2015-02-12 Pi Ceramic Gmbh Keramische Technologien Und Bauelemente Piezokeramischer werkstoff mit reduziertem bleigehalt
WO2015038075A1 (en) 2013-09-16 2015-03-19 Agency For Science, Technology And Research Method
KR20170005854A (ko) 2014-05-18 2017-01-16 칠드런'즈 메디컬 센터 코포레이션 엑소솜과 관련된 방법 및 조성물
EP3193890A4 (en) 2014-09-15 2018-03-14 Agency For Science, Technology And Research Methods of treating graft versus host disease (gvhd) or epidermolysis bullosa (eb) with exosomes
CN105769916B (zh) 2016-04-29 2019-07-23 南京大学 间充质干细胞来源外泌体在制备治疗子痫前期药物或者制剂中的应用
KR20230067715A (ko) 2016-06-17 2023-05-16 유나이티드 쎄러퓨틱스 코포레이션 향상된 효능을 가진 세포외 소포
KR101973284B1 (ko) 2017-01-16 2019-04-29 사회복지법인 삼성생명공익재단 신생아 ｈｉｅ 치료용 조성물
WO2018183825A1 (en) 2017-03-31 2018-10-04 Wisconsin Alumni Research Foundation Generation of therapeutic cells using extracellular components of target organs
CN111212653A (zh) 2017-08-15 2020-05-29 儿童医学中心公司 经纯化间充质干细胞外排体及其用途
JP7538044B2 (ja) 2018-04-30 2024-08-21 ザ チルドレンズ メディカル センター コーポレーション 間葉系間質細胞エキソソームおよびそれらの使用
US20210213056A1 (en) 2018-05-09 2021-07-15 Children's Medical Center Corporation Mesenchymal stromal cell exosome-treated monocytes and uses thereof
EP3846782A4 (en) 2018-09-05 2022-07-13 Children's Medical Center Corporation USE OF MESENCHYMAL STROMIC CELLEXOSOMES IN PRENATAL THERAPY

Also Published As

Publication number Publication date
US20200281983A1 (en) 2020-09-10
JP2017517505A (ja) 2017-06-29
WO2015179227A1 (en) 2015-11-26
AU2015264519B2 (en) 2021-01-28
ES2929725T3 (es) 2022-12-01
CN106714781B (zh) 2021-08-10
CN113817672A (zh) 2021-12-21
KR20170005854A (ko) 2017-01-16
CA2949083C (en) 2023-10-10
AU2015264519A1 (en) 2016-12-15
US11759481B2 (en) 2023-09-19
JP6773563B2 (ja) 2020-10-21
US20170258840A1 (en) 2017-09-14
EP3145493A1 (en) 2017-03-29
CN106714781A (zh) 2017-05-24
JP2021020908A (ja) 2021-02-18
CA2949083A1 (en) 2015-11-26
US10624929B2 (en) 2020-04-21
EP3145493B1 (en) 2022-07-27
EP3145493A4 (en) 2018-05-30
IL249011B (en) 2021-12-01
IL249011A0 (en) 2017-01-31

Similar Documents

Publication Publication Date Title
DK3145493T3 (da) Fremgangsmåder og sammensætninger vedrørende exosomer
DK3234133T3 (da) Crispr-baserede sammensætninger og fremgangsmåder til anvendelse
KR20180084891A (ko) 구조 조성물 및 방법
GB2535253B (en) Compositions and methods
DK3221363T3 (da) Antistoffer mod cd73 og anvendelser deraf
DK3495023T3 (da) Semifluorerede forbindelser og sammensætninger deraf
DK3169741T3 (da) Forbedrede bindemiddelsammensætninger og anvendelser deraf
DK3215147T3 (da) Neurodæmpende norketamin-forbindelser og fremgangsmåder
DK3104718T3 (da) Tobaksholdig gelsammensætning
DK3015526T3 (da) Hydrofluorolefinbaseret sammensætning og anvendelse deraf
DK3218358T3 (da) Ifluorometyl-aminopyridiner og difluorometyl-aminopyrimidiner
DK3089741T3 (da) Farmaceutiske sammensætninger omfattende azd9291
DK3542812T3 (da) Glycopeptidsammensætninger
DK3040326T3 (da) Haloolefin-baseret sammensætning
DK3102200T3 (da) Terapeutisk forbindelse og sammensætning
DK3194564T3 (da) Trichodermasammensætninger og anvendelsesfremgangsmåder
FR3024363B1 (fr) Composition thermogelifiable
DK3324932T3 (da) Sammensætninger og fremgangsmåder for nanopartikel lyofile former
DK3212776T3 (da) Sammensætninger og fremgangsmåder i forbindelse med beta-glucosidase
DK3129007T3 (da) Vaccinesammensætninger
CL2017000639A1 (es) Composición
DK3331498T3 (da) Nasalsammensætning
DK3223846T3 (da) Adjuvanssammensætninger og tilhørende fremgangsmåder
DK3166960T3 (da) Lav-substituerede polymyxiner og sammensætninger deraf
DK3200827T3 (da) Sammensætninger